Comparing the effectiveness of enhanced motivational interviewing with usual care for reducing cardiovascular risk

Conditions

Cardiovascular disease (CVD) Circulatory System Cardiovascular disease, unspecified

Khalida Ismail, Daniel Ståhl, Adam Bayley, Katherine Twist, Kurtis Stewart et al. (16 authors)

Health Technology Assessment2019-12-0122 citations

Response bias to a randomised controlled trial of a lifestyle intervention in people at high risk of cardiovascular disease: a cross-sectional analysis.

Bayley A, Stahl D, Ashworth M, Cook DG, Whincup PH, Treasure J, Greenough A, Ridge K, Winkley K, Ismail K.

2018-09-0414 citations

10.1186/s12889-018-5939-y

Association between depressive symptoms and objectively measured daily step count in individuals at high risk of cardiovascular disease in South London, UK: a cross-sectional study

Vera Miriam Ludwig, Adam Bayley, Derek G. Cook, Daniel Ståhl, Janet Treasure et al. (10 authors)

BMJ Open2018-04-0135 citations

10.1136/bmjopen-2017-020942

Comparing the effectiveness of an enhanced MOtiVational intErviewing InTervention (MOVE IT) with usual care for reducing cardiovascular risk in high risk subjects: study protocol for a randomised controlled trial.

Bayley A, de Zoysa N, Cook DG, Whincup PH, Stahl D, Twist K, Ridge K, McCrone P, Treasure J, Ashworth M, Greenough A, Blythe C, Winkley K, Ismail K.

2015-03-2514 citations

10.1186/s13063-015-0593-5

Interventions

The intervention will be based on the Theory of Planned Behaviour (TPB) for initiation of behaviour change. The TPB states that in order to change behaviour, people need to form an intention. Intentio

evocation (as opposed to didactic reasoning) and patient autonomy (as opposed to authoritative style) The key skills in MI are the ability to express empathy (which includes understan

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Being fluent in conversational English 2. Permanent residents and planning to stay in the UK at least ¾ of year. In our local experience of conducting epidemiology and clinical trial studies, 5% of the African, Caribbean and South Asian population are itinerant which increases the risk of attrition, non-completion of the intervention and difficulty of measuring post-randomization factors.

Exclusion criteria

Exclusion criteria: 1. Established cardiovascular (CVD) disease 2. Severe mental illness such as psychosis, learning disability, dementia and cognitive impairment 3. Registered blind 4. Housebound or resident in nursing home 5. Unable to move about independently 6. > 3 falls in past year 7. Pregnancy 8. Advanced cancer 9. Morbid obesity body mass index (BMI) >50 kg/m2 10. Current participation in a weight loss programme. When in doubt we will seek the GP opinion and approval

Design outcomes

Primary

Measure	Time frame
Differences in weight (kilograms) and in physical activity (number of timed steps) between arms at 24 months (interim outcome at 12 months). Weight using the Tanita SC240 digital weighing scale and physical activity using the Actigraph GT3X accelerometer at all time points.	—

Secondary

Measure	Time frame
1. Differences in: lipids, blood pressure, HbA1c, and CVD risk and in smoking status at 24 months 2. The EQ-5D will be used to generate quality-adjusted life years 3. Intervention costs will include training and delivering interventions, overheads and other service use will be measured using an adapted Client Service Receipt Inventory. Costs will be calculated by combining service use data with unit costs.	—

Measure

Time frame

1. Differences in: lipids, blood pressure, HbA1c, and CVD risk and in smoking status at 24 months 2. The EQ-5D will be used to generate quality-adjusted life years 3. Intervention costs will include training and delivering interventions, overheads and other service use will be measured using an adapted Client Service Receipt Inventory. Costs will be calculated by combining service use data with unit costs.

—

Countries

United Kingdom

Outcome results

None listed